Sienna Biopharmaceuticals, Inc. (SNNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 30699 RUSSELL RANCH ROAD, SUITE 140
WESTLAKE VILLAGE, CA 91362
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49,20757,16948,52663,97574,88760,013
Cash and cash equivalents49,20757,16948,52663,97574,88760,013
Restricted cash and investments181181181181181181
Other undisclosed current assets1,2291,3191,7052,9032,5732,198
Total current assets:50,61758,66950,41267,05977,64162,392
Noncurrent Assets
Operating lease, right-of-use asset  
Property, plant and equipment237275311345371397
Intangible assets, net (including goodwill) 10,88710,74710,98911,11411,20711,799
Goodwill 10,88710,74710,98911,11411,20711,799
Other undisclosed noncurrent assets45,88445,36345,59446,11246,50148,956
Total noncurrent assets:57,00856,38556,89457,57158,07961,152
TOTAL ASSETS:107,625115,054107,306124,630135,720123,544
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,7137,85310,63613,59613,1328,907
Employee-related liabilities1,9451,5373,0573,0251,8751,522
Accounts payable1,5222,1802,7923,4794,1801,863
Accrued liabilities3,2464,1364,7877,0927,0775,522
Business combination, contingent consideration, liability 14,10014,60013,500   
Other undisclosed current liabilities   213213213213
Total current liabilities:20,81322,45324,34913,80913,3459,120
Noncurrent Liabilities
Long-term debt and lease obligation 29,47429,23730,12529,98329,897 
Long-term debt, excluding current maturities 29,47429,23730,12529,98329,897 
Liabilities, other than long-term debt 29,81129,49126,20335,12235,91235,677
Deferred tax liabilities, net10,40610,27210,50310,62210,71211,277
Other liabilities 519    
Business combination, contingent consideration, liability 19,40019,20015,70024,50025,20024,400
Other undisclosed noncurrent liabilities544587487861,0322,324
Total noncurrent liabilities:59,82959,31556,37665,89166,84138,001
Total liabilities:80,64281,76880,72579,70080,18647,121
Equity
Equity, attributable to parent26,98333,28626,58144,93055,53476,423
Additional paid in capital208,261206,886182,750181,108174,523172,679
Accumulated other comprehensive income2,7722,1863,1993,8554,2506,744
Accumulated deficit(184,050)(175,786)(159,368)(140,033)(123,239)(103,000)
Total equity:26,98333,28626,58144,93055,53476,423
TOTAL LIABILITIES AND EQUITY:107,625115,054107,306124,630135,720123,544

Income Statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues
(Sublease Income)
      
Gross profit:      
Operating expenses(7,727)(15,839)(19,769)(16,584)(21,668)(18,477)
Other undisclosed operating loss      
Operating loss:(7,727)(15,839)(19,769)(16,584)(21,668)(18,477)
Nonoperating income (expense)(537)(543)434(210)1,4291,374
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before income taxes:(8,264)(16,382)(19,335)(16,794)(20,239)(17,103)
Income tax benefit      
Loss from continuing operations:(8,264)(16,382)(19,335)(16,794)(20,239)(17,103)
Loss before gain (loss) on sale of properties:(8,264)(16,382)(19,335)(16,794)(20,239)(17,103)
Net loss available to common stockholders, diluted:(8,264)(16,382)(19,335)(16,794)(20,239)(17,103)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(8,264)(16,382)(19,335)(16,794)(20,239)(17,103)
Other undisclosed comprehensive loss   (2,171)   
Comprehensive loss:(8,264)(16,382)(21,506)(16,794)(20,239)(17,103)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent586(1,013)1,515(396)(2,494)1,374
Comprehensive loss, net of tax, attributable to parent:(7,678)(17,395)(19,991)(17,190)(22,733)(15,729)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: